Loading Page..

Knowledge Content Library

373
A "Cap & Trade" Approach to Assessing Technical Success Probabilities in Pharma
Presented by Chris Dalton (Syncopation Software) at 2017 DAAG Conference in New Orleans. In this session on Learning and Organization, this talk discusses probability assessment in the context of pharma/biotech R&D portfolio management.

388
The Value of Streamgage Information: A case study evaluating the use and value of streamgage data for culvert design and operations
Presented by Emily Pindilli (US Geological Survey) at 2017 DAAG Conference in New Orleans. In this session on Information Value, this talk discusses considers the use and value of streamflow information for the design and operation of culverts.

389
Making Better Appraisal & Development Decisions Using Decision Risk Analysis & Value of Information
Presented by Pete Naylor at 2017 DAAG Conference in New Orleans. In this session on Information Value, this talk provides an overview of value of information methods.

371
The Value and Danger of “Story” in Getting to Commitment to Action
Presented by Elayne Ko (Pfizer) and Charles Persinger (Eli Lilly) at 2017 DAAG Conference in New Orleans. In this session on Facilitation and Collaboration, this talk discusses both the value and danger of using stories to facilitate commitment to action.

369
Selecting a Preferred Alternative To Meet Tier 3 Gasoline Requirements
Presented by Rob Lazenby (Chevron) at 2017 DAAG Conference in New Orleans. In this session on Risk Assessment and Management, this talk discusses the use of DA techniques to determine a refinery's strategy to meet gasoline specifications.

370
Oil Market Disruption Risks
Presented by Phil Beccue (White Deer Partners) at 2017 DAAG Conference in New Orleans. In this session on Risk Assessment and Management, this talk discusses a risk assessment of potential future oil disruptions and impacts to the US Strategic Petroleum Reserve.

367
Building and Nurturing the Company Culture You Want
Presented by Patrick Leach (Independent Consultant) at 2017 DAAG Conference in New Orleans. In this session on Culture, this talk discusses the relationship between previously held beliefs and new evidence.

368
The Intersection of Culture and Quality Decision Making
Presented by Eyas Raddad (Eli Lilly) at 2017 DAAG Conference in New Orleans. In this session on Culture, this talk discusses decision making based on the intersection of the Dimensions of Culture and Quality Decision Making.

355
Modeling Ordered Uncertainties
Presented by Jon Mauer (Pfizer) at 2016 DAAG Conference in Banff. In this session on The Cutting Edge of Decision Analysis, this short talk looks at complex correlated uncertainties in a pharma problem.

324
Overthrowing the Tyranny of Economics
Presented by Patrick Leach (Decision Strategies) at 2016 DAAG Conference in Banff. In this session on Unsolved Problems and Developing Ideas, this short talk provides suggestions for revising economics to account for natural and social capital, as well as financial capital.

326
When is Enough, Enough?
Presented by Elayne Ko (Pfizer) at 2016 DAAG Conference in Banff. In this session on Unsolved Problems and Developing Ideas, this short presentation provides talking points for a discussion of requisite decision models.

327
Decision Analysis Concepts and Other Approaches
Presented by Henk Krijnen (NavIncerta) at 2016 DAAG Conference in Banff. In this session on Unsolved Problems and Developing Ideas, this short talk discusses some incompatibilities in how discount rates are chosen.

328
Real Estate Diagrams
Presented by Jim Felli (Eli Lilly) at 2016 DAAG Conference in Banff. In this session on Unsolved Problems and Developing Ideas, this short talk discusses the use of real estate diagrams to map an event's prevalence in a population and the presumed sensitivity and specificity of a proposed test.

329
What If We Are Wrong? Asymmetric Risk Assessment
Presented by Bill Haskett (Decision Strategies) at 2016 DAAG Conference in Banff. In this session on Unsolved Problems and Developing Ideas, this short talk looks at asymmetric risks applied to a drilling example.

325
Improved Drug Treatment Decisions Through Consistent Benefit‐Risk Tradeoffs
Presented by Jack Kloeber (Kromite) at 2016 DAAG Conference in Banff. In this session on Medical Decision Making, this talk discusses the use of multi-objective decision analysis to aid physicians in finding effective ways to measure and communicate the differences in treatment benefits and risks.

321
A Must Do Project Without the Required Capital
Presented by Jerry Lieberman (Endeavor Management) at 2016 DAAG Conference in Banff. In this session on Capital Decision Making Under Resource Constrained Circumstances, this Case Study illustrates several ideas with widespread applicability for developing an economically viable project in a severely resource constrained environment.

332
Turning the Supertanker - Structured Decision‐Making at BC Hydro
Presented by Basil Stumborg (BC Hydro) at 2016 DAAG Conference in Banff. In this session on Capital Decision Making Under Resource Constrained Circumstances, this presentation provides an overview of the use of Structured Decision Making in BC Hydro.

330
The ABCDs of Informal DA in Neighborhood Non-profits
Presented by Enrico Manlapig (Westmont College) at 2016 DAAG Conference in Banff. In this session on Societal and Non-Profit Decision Making, this talk discusses how DA helped a school board choose a new facility.

335
Supporting Landscape Level Planning and Management with DA-facilitated Integrated Science Modeling
Presented by Karen Jenni (USGS) and Tim Nieman (Decision Application) at 2016 DAAG Conference in Banff. In this session on Societal and Non-Profit Decision Making, this talk discusses the unique and interesting modeling and communication challenges associated with effective decision support in very large, complex multiple stakeholder situations.

399
DA for Financial Stability in a Conservation Org
Presented by Esteban Guerrero (SmartOrg) at 2016 DAAG Conference in Banff. In this session on Societal and Non-Profit Decision Making, this talk discusses how Portfolio Decision Analysis made a big dent in helping project champions understand and manage the complexity of debt swaps.

Stay connected